These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31365378)

  • 61. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders].
    Lederer C; Buschulte K; Hellmich B; Heußel CP; Kriegsmann M; Polke M; Kreuter M
    Inn Med (Heidelb); 2023 Mar; 64(3):247-259. PubMed ID: 36786822
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF.
    Tóth NM; Müller V; Nagy T; Polivka L; Horváth P; Bohács A; Eszes N
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298130
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum C-reactive protein is associated with earlier mortality across different interstitial lung diseases.
    Stock CJW; Bray WG; Kouranos V; Jacob J; Kokosi M; George PM; Chua F; Wells AU; Sestini P; Renzoni EA
    Respirology; 2024 Mar; 29(3):228-234. PubMed ID: 37779266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors influencing long-term outcomes in fibrotic interstitial lung disease (F-ILD) diagnosed through multidisciplinary discussion (MDD): a prospective cohort study.
    Liao YW; Liu MC; Wu YC; Hsu CY; Huang WN; Chen YH; Fu PK
    Eur J Med Res; 2024 Jan; 29(1):91. PubMed ID: 38291459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.
    Mononen M; Saari E; Hasala H; Kettunen HP; Suoranta S; Nurmi H; Kärkkäinen M; Selander T; Randell J; Laurikka J; Uibu T; Koskela H; Kaarteenaho R; Purokivi M
    BMC Pulm Med; 2022 Aug; 22(1):313. PubMed ID: 35965320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Suda T
    Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):155-62. PubMed ID: 27279757
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
    Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of Multidisciplinary Team Meetings in the Diagnosis and Management of Diffuse Parenchymal Lung Diseases in a Tertiary Care Hospital.
    Khan MA; Sherbini N; Alyami S; Al-Harbi A; Alrajhi S; Abdullah R; AlGhamdi D; Rajendram R; Bamefleh H; Al-Jahdali H
    Avicenna J Med; 2023 Oct; 13(4):230-236. PubMed ID: 38144909
    [No Abstract]   [Full Text] [Related]  

  • 70. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.
    Puiu R; Motoc NS; Lucaciu S; Ruta MV; Rajnoveanu RM; Todea DA; Man MA
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunomodulatory treatment of interstitial lung disease.
    van den Bosch L; Luppi F; Ferrara G; Mura M
    Ther Adv Respir Dis; 2022; 16():17534666221117002. PubMed ID: 35938712
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification.
    Brixey AG; Oh AS; Alsamarraie A; Chung JH
    Chest; 2024 Apr; 165(4):908-923. PubMed ID: 38056824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Overview of Progressive Fibrotic Interstitial Lung Disease.
    Case AH
    Front Med (Lausanne); 2022; 9():858339. PubMed ID: 35372405
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical features of acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: Comparison with idiopathic pulmonary fibrosis.
    Otsuka J; Yoshizawa S; Kudo K; Osoreda H; Ishimatsu A; Taguchi K; Moriwaki A; Wakamatsu K; Iwanaga T; Yoshida M
    Respir Med; 2022; 200():106898. PubMed ID: 35696743
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease.
    Bes C; Köybaşı G; İçaçan OC; Yalçın Mutlu M; Yıldırım F
    Eur J Rheumatol; 2022 Jul; 9(3):176-179. PubMed ID: 35156636
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interstitial Lung Disease Associated with Connective Tissue Diseases.
    Peredo RA; Mehta V; Beegle S
    Adv Exp Med Biol; 2021; 1304():73-94. PubMed ID: 34019264
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.
    Brito Y; Glassberg MK; Ascherman DP
    Curr Rheumatol Rep; 2017 Nov; 19(12):79. PubMed ID: 29119259
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
    Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.